1 Turning Point Therapeutics Inc. Receivables Turnover Ratio (TPTX), from the second quarter 2022 to the second quarter 2021 current and historic results, rankings and more - CSIMarket

Company Name, Ticker, Industry, else..

Growth Rates

Profitability

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

• Sales per Employee

• Income per Employee

• Inventory Turnover

• Asset Turnover

• Receivables Turnover

Dividend Comparisons

Turning Point Therapeutics Inc. (NASDAQ: TPTX)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Turning Point Therapeutics Accounts Receivables Turnover Ratio from the second quarter 2022 to the second quarter 2021

Quarterly Results, Trends, Rankings, Statistics

According to Turning Point Therapeutics Inc. Balance Sheet, in the second quarter 2022, company has not reported any Accounts receivable.
See Turning Point Therapeutics Inc. Balance Sheet

If we take a look into Healthcare sector 703 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2022 from 4334 to 4343.

What is Receivable Turnover Ratio?
What is Turning Point Therapeutics Inc. Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TPTX Receivables Turnover Ratio	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	-97.7 %	-98.3 %	-	-98.16 %	-
Receivable Turnover Ratio (TTM)	-	-	-	-	-
TPTX's Total Ranking	# 4343	# 4334	# 4145	# 3326	# 0
Accounts Receivable average collection period days	-	-	-	-	-
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	-72.26 %	1.2075276500887E+16 %	-100 %	-91.09 %	-79.51 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 288
Healthcare Sector	# 704
Overall Market	# 4343

Receivable Turnover Ratio Statistics
High	Average	Low
0.06	0.02	0
(Sep 30 2021)		(Jun 30 2022)

TPTX Company Profile • Back to TPTX Efficiency Comparisons • Compare TPTX Receivables Turnover Ratio to its Competitors

Financial Statements
Turning Point Therapeutics's Accounts Receivable	$ 0 Millions	Visit TPTX's Balance sheet
Turning Point Therapeutics's Sales TTM	$ 1 Millions	Visit TPTX's Income Statement
Sources of TPTX's Revenues		Visit TPTX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
TPTX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
TPTX's Growth Rates	TPTX's Roa	TPTX's Inventory Turnover Ratio	TPTX's Dividend Comparisons
TPTX's Profitability Ratios	TPTX's Roi	TPTX's Asset Turnover Ratio	TPTX's Dividend Growth
TPTX's Valuation Ratios	TPTX's Roe	TPTX's Financial Strength Ratios	TPTX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2022, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Jun 30 2022

Receivable at quarter ending Jun 30 2022

Date modified: 2026-09-18T13:11:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.